NCT01760915View on ClinicalTrials.gov

University of Wisconsin Severe Asthma Research Program III

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

November 28, 2012

Primary Completion Date

March 24, 2020

Study Completion Date

December 17, 2021

Conditions
Asthma
Interventions
OTHER

NC100182 Hyperpolarized 3He

Magnetic Resonance Imaging (MRI) will take place and include inhalation of hyperpolarized helium to construct an image of the lungs.

Trial Locations (1)

53792

UW Madison, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Washington University School of Medicine

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT01760915 - University of Wisconsin Severe Asthma Research Program III | Biotech Hunter | Biotech Hunter